Medically reviewed by Kashif J. Piracha, MD Fasting for blood work is a common requirement. Fasting requires not eating food ...

GLP-1 agonists substantially slowed kidney deterioration and failure, independent of diabetes status. The most extensive and ...

Patients with a GFR below 30 should avoid using glimepiride. Managing your diet, weight, physical activity, and smoking habits can have a positive impact on managing diabetes and protecting the ...

1 Department of Urology, School of Rehabilitation, China Rehabilitation Research Center, Beijing Bo’ai Hospital, Capital Medical University, Beijing, China 2 China Rehabilitation Science Institute, ...

As per Intent Market Research, the Cystatin C Assay Market was valued at USD 357 million in 2023 and will surpass USD 571 ...

The calculator includes patient age, sex, cholesterol, systolic blood pressure, body mass index, estimated glomerular filtration rate, diabetes and smoking status, medication use, and, if ...

"A reduction or absence of ankle reflexes is strongly and independently linked to a decline in estimated glomerular ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) significantly reduce the risk for clinically meaningful chronic kidney disease (CKD) progression and major adverse cardiovascular events (MACE) in ...

The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without ...

had only impaired GFR (eGFR < 60 ml/min/1.73 m 2), and 63 (74%) had only proteinuria. When it was analyzed with multivariate logistic regression, hypertension, >10 years duration of diabetes, and ...

Research found that younger age at type 2 diabetes diagnosis is associated with higher risks of cardiovascular and all-cause ...

Vertex Pharmaceuticals Incorporated looks set for two new drug approvals in early 2025. Click here to read an analysis of ...